Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tefludazine, a novel neuroleptic with a benzindone structure, is a compound with good oral activity and antagonistic effects on dopamine and 5-hydroxytryptamine receptors. Tefludazine has shown potent dopamine (DA) antagonistic activity in in vitro and in vivo test models in mice, rats and dogs. Tefludazine is a therapeutic agent used to treat psychiatric disorders.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 55,000 |
5 mg | 在庫あり | ¥ 135,500 |
10 mg | 在庫あり | ¥ 193,500 |
25 mg | 在庫あり | ¥ 294,000 |
50 mg | 在庫あり | ¥ 397,000 |
100 mg | 在庫あり | ¥ 535,000 |
500 mg | 在庫あり | ¥ 1,072,000 |
説明 | Tefludazine, a novel neuroleptic with a benzindone structure, is a compound with good oral activity and antagonistic effects on dopamine and 5-hydroxytryptamine receptors. Tefludazine has shown potent dopamine (DA) antagonistic activity in in vitro and in vivo test models in mice, rats and dogs. Tefludazine is a therapeutic agent used to treat psychiatric disorders. |
In vivo | The data suggests that the potential antipsychotic compound Tefludazine should not induce neurological side effects at lower doses but still has an antipsychotic activity while repeated treatment with higher doses of Tefludazine might cause extrapyramidal side effects.[2] |
分子量 | 408.43 |
分子式 | C22H24F4N2O |
CAS No. | 80680-06-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (134.66 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tefludazine 80680-06-4 Inhibitor inhibitor inhibit